IL160435A0 - Preparation and diabetic use of gibberellins - Google Patents

Preparation and diabetic use of gibberellins

Info

Publication number
IL160435A0
IL160435A0 IL16043502A IL16043502A IL160435A0 IL 160435 A0 IL160435 A0 IL 160435A0 IL 16043502 A IL16043502 A IL 16043502A IL 16043502 A IL16043502 A IL 16043502A IL 160435 A0 IL160435 A0 IL 160435A0
Authority
IL
Israel
Prior art keywords
gibberellins
preparation
diabetic
diabetic use
nephropathy
Prior art date
Application number
IL16043502A
Other languages
English (en)
Original Assignee
Australian Biomedical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR7380A external-priority patent/AUPR738001A0/en
Priority claimed from AU2002950182A external-priority patent/AU2002950182A0/en
Application filed by Australian Biomedical Company filed Critical Australian Biomedical Company
Publication of IL160435A0 publication Critical patent/IL160435A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16043502A 2001-08-31 2002-08-12 Preparation and diabetic use of gibberellins IL160435A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR7380A AUPR738001A0 (en) 2001-08-31 2001-08-31 Compound for medicinal purposes
AU2002950182A AU2002950182A0 (en) 2002-07-12 2002-07-12 Compounds for medicinal purposes
PCT/AU2002/001083 WO2003018069A1 (en) 2001-08-31 2002-08-12 Preparation and diabetic use of gibberellins

Publications (1)

Publication Number Publication Date
IL160435A0 true IL160435A0 (en) 2004-07-25

Family

ID=25646789

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16043502A IL160435A0 (en) 2001-08-31 2002-08-12 Preparation and diabetic use of gibberellins

Country Status (20)

Country Link
US (3) US7435756B2 (xx)
EP (1) EP1420774B1 (xx)
JP (2) JP4596777B2 (xx)
KR (1) KR100898519B1 (xx)
CN (1) CN1242741C (xx)
AT (1) ATE401876T1 (xx)
AU (1) AU2002322165B2 (xx)
BR (1) BR0212150A (xx)
CA (1) CA2458797C (xx)
CY (1) CY1108394T1 (xx)
DE (1) DE60227820D1 (xx)
DK (1) DK1420774T3 (xx)
ES (1) ES2309187T3 (xx)
HK (1) HK1069778A1 (xx)
IL (1) IL160435A0 (xx)
NZ (1) NZ530990A (xx)
PT (1) PT1420774E (xx)
RU (1) RU2310444C2 (xx)
WO (1) WO2003018069A1 (xx)
ZA (1) ZA200401549B (xx)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB821733A (en) * 1957-04-05 1959-10-14 Ici Ltd Isolation process
GB1174924A (en) * 1966-11-03 1969-12-17 Ici Ltd Separation Process for Gibberellic Acid
ATE5538T1 (de) * 1979-09-04 1983-12-15 Norsk Hydro A/S Fermentationsverfahren zur herstellung eines gibberellins.
JPS58152499A (ja) * 1982-03-05 1983-09-10 Kyowa Hakko Kogyo Co Ltd ジベレリンa4の製造法
US4424232A (en) * 1982-05-19 1984-01-03 Parkinson Richard W Treatment of herpes simplex
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
JPH025531A (ja) * 1988-06-24 1990-01-10 Matsushita Electron Corp 半導体装置の製造方法
JP2797331B2 (ja) * 1988-08-31 1998-09-17 三菱化学株式会社 新規微生物及びジベレリン類の製造方法
JPH02165775A (ja) 1988-12-20 1990-06-26 Toshiba Corp 画像処理装置
US5580857A (en) * 1989-12-12 1996-12-03 Oden; Per Use of gibberellins for the treatment of prostatitis
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
WO1996020703A1 (en) * 1995-01-06 1996-07-11 Australian Biomedical Company Pty. Ltd. Compounds for veterinary and medicinal applications
JPH11508894A (ja) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Ace阻害剤とaii拮抗薬を用いる腎疾患の治療方法
IT1276130B1 (it) * 1995-11-14 1997-10-27 Gentili Ist Spa Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
US6312663B1 (en) * 1999-03-19 2001-11-06 Joseph V. Boykin, Jr. Prediction of diabetes impaired wound healing by urinary nitrate assay
US6287800B1 (en) * 1999-08-31 2001-09-11 Jorge L. Gallazzo Production of high titers of gibberellins, GA4 and GA7, by Gibberella fujikuroi strain LTB-1027

Also Published As

Publication number Publication date
NZ530990A (en) 2005-08-26
JP2009100775A (ja) 2009-05-14
WO2003018069A1 (en) 2003-03-06
US7968596B2 (en) 2011-06-28
HK1069778A1 (en) 2005-06-03
US20070197456A1 (en) 2007-08-23
ES2309187T3 (es) 2008-12-16
RU2310444C2 (ru) 2007-11-20
CA2458797A1 (en) 2003-03-06
EP1420774A1 (en) 2004-05-26
US20050215496A1 (en) 2005-09-29
CN1242741C (zh) 2006-02-22
ATE401876T1 (de) 2008-08-15
PT1420774E (pt) 2008-08-11
JP4885989B2 (ja) 2012-02-29
KR100898519B1 (ko) 2009-05-20
JP4596777B2 (ja) 2010-12-15
CN1543343A (zh) 2004-11-03
US20040162248A1 (en) 2004-08-19
KR20040031008A (ko) 2004-04-09
US7435756B2 (en) 2008-10-14
AU2002322165B2 (en) 2006-10-26
EP1420774B1 (en) 2008-07-23
BR0212150A (pt) 2004-07-13
ZA200401549B (en) 2005-01-26
EP1420774A4 (en) 2006-07-05
DK1420774T3 (da) 2008-11-24
CY1108394T1 (el) 2014-02-12
DE60227820D1 (de) 2008-09-04
CA2458797C (en) 2011-01-18
JP2005501864A (ja) 2005-01-20

Similar Documents

Publication Publication Date Title
CA2382480A1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
WO2009023718A3 (en) Novel activators of glucokinase
MY132789A (en) Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals
WO2004026863A8 (en) Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors
IL166748A0 (en) Pyrazole derivative medicinal composition containing the same medicinal use thereof and intermediatefor production thereof
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY140187A (en) Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
WO2002081453A8 (fr) Hiohydantoïnes et leur utilisation dans le traitement du diabete
BRPI0313694B8 (pt) derivados de pirazol, composição medicinal contendo os mesmos, seu uso medicinal e intermediários para sua produção
BR9906813A (pt) Método para administração de insulina aspb28- humana
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
AU2003282234A1 (en) Benzofuran derivates, process for their preparation and intermediates thereof
WO2003051389A3 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
GEP20053492B (en) 5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl- [2,3']Bipyridinyl in Pure Crystalline Form and Process for Production Thereof
WO2005016867A3 (en) Anthranilic acid derivatives and their use as activators of the hm74a receptor
WO2003028715A3 (en) Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis
WO2002087596A3 (en) Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
WO2006138043A3 (en) Method and compositions for the treatment of diabetes and related complications
WO2000078724A3 (en) Imidazolinderivatives their preparation and their pharmaceutical use
EP1550668A4 (en) PYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION COMPRISING THE DERIVATIVE, MEDICINAL USE THEREOF, AND INTERMEDIATE ENTERING THE PRODUCTION THEREOF
IL160435A0 (en) Preparation and diabetic use of gibberellins
CN110372663A (zh) 含硫杂环化合物及其作为dpp4抑制剂衍生物的应用
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
KR20180053032A (ko) 신규한 피페린 유도체 및 이를 포함하는 약학적 조성물

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed